Insulin glargine, recombinant Subcutaneous and Scopolamine Injection
Determining the interaction of Insulin glargine, recombinant Subcutaneous and Scopolamine Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
Generic Name: scopolamine
Brand name: Transderm-Scop
Synonyms: Scopolamine transdermal, Scopolamine (Systemic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine, recombinant Subcutaneous-Scopolamine Patch
- Insulin glargine, recombinant Subcutaneous-Scopolamine transdermal
- Insulin glargine, recombinant Subcutaneous-Scopolamine Transdermal Patch
- Insulin glargine, recombinant Subcutaneous-Scot-Tussin Allergy Relief Formula
- Insulin glargine, recombinant Subcutaneous-Scot-Tussin Diabetic
- Insulin glargine, recombinant Subcutaneous-Scot-Tussin DM
- Scopolamine Injection-Insulin glulisine
- Scopolamine Injection-Insulin Glulisine (Cartridges and Pens)
- Scopolamine Injection-Insulin Glulisine (Vials)
- Scopolamine Injection-Insulin glulisine Subcutaneous
- Scopolamine Injection-Insulin human inhaled Inhalation
- Scopolamine Injection-Insulin human regular Injection